BioMarin Pharmaceutical I... (BMRN)
NASDAQ: BMRN
· Real-Time Price · USD
53.85
1.23 (2.34%)
At close: Sep 26, 2025, 3:59 PM
54.00
0.28%
After-hours: Sep 26, 2025, 07:56 PM EDT
BioMarin Pharmaceutical Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | 812.98M | 734.64M | 735.63M | 733.87M | 702.13M | 637.82M | 633.15M | 568.27M | 584.7M | 586.43M | 525.49M | 493.35M | 517.66M | 505.52M | 435.22M | 393.84M | 486.67M | 18.26M | 437.05M | 16.04M | 10.45M | 489.04M | 436.58M | 450.9M | 379.07M | 394.48M | 6.06M | 386.32M | 367.79M |
| Product Revenue Growth | +10.66% | -0.13% | +0.24% | +4.52% | +10.08% | +0.74% | +11.42% | -2.81% | -0.29% | +11.60% | +6.52% | -4.70% | +2.40% | +16.15% | +10.51% | -19.07% | +2565.08% | -95.82% | +2624.21% | +53.48% | -97.86% | +12.02% | -3.17% | +18.95% | -3.91% | +6406.40% | -98.43% | +5.04% | n/a |
| Royalty And Other Revenue | 12.43M | 10.5M | 11.68M | 11.87M | 9.9M | 11.02M | 13.06M | 13.06M | 10.58M | 9.99M | 12.05M | 12M | 16.14M | 13.83M | 14.59M | 14.9M | 15.02M | n/a | 15.07M | n/a | n/a | 13.03M | 17.86M | n/a | n/a | n/a | n/a | n/a | n/a |
| Royalty And Other Revenue Growth | +18.35% | -10.09% | -1.63% | +19.93% | -10.15% | -15.63% | -0.03% | +23.50% | +5.89% | -17.08% | +0.42% | -25.67% | +16.65% | -5.19% | -2.09% | -0.81% | n/a | n/a | n/a | n/a | n/a | -27.06% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Europe Revenue | 115.5M | 172.68M | 161.84M | 143.01M | 121.16M | 109.26M | 145.04M | 139.6M | 125.48M | 119.56M | 124.54M | 112.49M | 111.07M | 107.22M | 27.77M | 72.71M | 97.83M | 64.93M | 66.02M | 61.73M | 62.82M | 64.8M | 63.28M | 50.64M | 42.82M | 43.58M | 41.71M |
| Europe Revenue Growth | -33.11% | +6.70% | +13.17% | +18.04% | +10.89% | -24.67% | +3.89% | +11.25% | +4.95% | -4.00% | +10.71% | +1.28% | +3.59% | +286.06% | -61.80% | -25.67% | +50.66% | -1.65% | +6.95% | -1.74% | -3.05% | +2.39% | +24.98% | +18.25% | -1.73% | +4.48% | n/a |
| Latin America Revenue | 38.96M | 42.25M | 59.7M | 64.01M | 44.06M | 37.86M | 59.92M | 54.66M | 83.8M | 46.49M | 33.84M | 33.09M | 55.32M | 58.16M | n/a | 60.61M | 26.36M | 58.2M | 37.26M | 40.67M | 38.79M | 49.63M | 18.38M | 15.16M | 25.59M | 66.74M | 34.82M |
| Latin America Revenue Growth | -7.79% | -29.24% | -6.73% | +45.27% | +16.37% | -36.81% | +9.63% | -34.77% | +80.24% | +37.40% | +2.26% | -40.18% | -4.88% | n/a | n/a | +129.98% | -54.72% | +56.20% | -8.37% | +4.84% | -21.85% | +170.06% | +21.25% | -40.76% | -61.66% | +91.69% | n/a |
| Rest Of World Revenue | 58.05M | 82.52M | 56.3M | 62.39M | 58.61M | 49.81M | 52.94M | 43.96M | 49.94M | 52.3M | 51.43M | 38.92M | 50.59M | 44.68M | n/a | 61.84M | 58.96M | 52.7M | 67.98M | 56.18M | 47.93M | 59.53M | 45.57M | 28.06M | 28.24M | 32.33M | 36.14M |
| Rest Of World Revenue Growth | -29.66% | +46.58% | -9.77% | +6.45% | +17.68% | -5.91% | +20.43% | -11.98% | -4.52% | +1.69% | +32.15% | -23.08% | +13.24% | n/a | n/a | +4.90% | +11.87% | -22.47% | +20.99% | +17.22% | -19.48% | +30.62% | +62.42% | -0.64% | -12.64% | -10.56% | n/a |
| United States Revenue | 196.24M | 204.25M | 208.19M | 182.7M | 252.95M | 232.55M | 244.17M | 216.22M | 201.87M | 169.41M | 190.94M | 168.71M | 174.72M | 162.79M | n/a | 163.14M | 151.01M | 141.61M | 132.49M | 141.51M | 130.36M | 126.17M | 109.5M | n/a | n/a | n/a | 90.59M |
| United States Revenue Growth | -3.92% | -1.89% | +13.95% | -27.77% | +8.77% | -4.76% | +12.93% | +7.11% | +19.17% | -11.28% | +13.17% | -3.44% | +7.33% | n/a | n/a | +8.03% | +6.64% | +6.89% | -6.38% | +8.56% | +3.32% | +15.22% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 232.28M | 206.12M | 170.78M | 253.48M | 263M | 225.9M | 275.02M | 172.6M | 216.78M | 218.38M | 245.74M | 216.82M | 196.84M | 194.62M | 217.56M | 183.33M | 184.16M | 174.32M | 195.51M | 179.45M | 175.41M | 187.29M | 187.9M | 170.11M | 160.75M | 162.16M | 164.17M | 148.57M | 153.28M | 138.34M | 160.28M | 130.53M | 143.5M | 120.02M | 142.96M | 118.76M | 109.58M | 105.3M | 113.91M | 94.04M | 101.51M | 92.81M |
| Selling, General, and Administrative Revenue Growth | +12.69% | +20.69% | -32.63% | -3.62% | +16.42% | -17.86% | +59.34% | -20.38% | -0.73% | -11.13% | +13.34% | +10.15% | +1.14% | -10.55% | +18.67% | -0.45% | +5.65% | -10.84% | +8.95% | +2.30% | -6.34% | -0.32% | +10.46% | +5.82% | -0.87% | -1.23% | +10.50% | -3.08% | +10.80% | -13.69% | +22.79% | -9.04% | +19.57% | -16.05% | +20.38% | +8.38% | +4.06% | -7.56% | +21.12% | -7.36% | +9.38% | n/a |
| Research and Development Revenue | 161.31M | 158.73M | 173.51M | 184.9M | 183.79M | 204.99M | 206.25M | 191.31M | 177.36M | 171.85M | 172.75M | 157.83M | 158.19M | 160.84M | 161.09M | 157.87M | 161.11M | 148.72M | 156.67M | 147.05M | 182.14M | 142.26M | 172.81M | 172.96M | 185.64M | 183.59M | 175.39M | 161.41M | 175.58M | 183.95M | 168.61M | 154.1M | 143.04M | 145M | 175.24M | 160.83M | 167.04M | 158.79M | 176.12M | 158.71M | 157.9M | 142.07M |
| Research and Development Revenue Growth | +1.62% | -8.52% | -6.16% | +0.61% | -10.34% | -0.61% | +7.81% | +7.87% | +3.21% | -0.52% | +9.45% | -0.23% | -1.65% | -0.16% | +2.04% | -2.01% | +8.33% | -5.07% | +6.54% | -19.26% | +28.04% | -17.68% | -0.09% | -6.83% | +1.12% | +4.68% | +8.66% | -8.07% | -4.55% | +9.10% | +9.41% | +7.73% | -1.35% | -17.26% | +8.96% | -3.72% | +5.19% | -9.84% | +10.97% | +0.51% | +11.14% | n/a |
| Sales and Marketing Revenue | 122.1M | 102.5M | 34.5M | 108.9M | 122.8M | 119.4M | 133.2M | 121.9M | 115.6M | 117.7M | 124.6M | 111.3M | 109.4M | 104.9M | 113.1M | 97M | 100.9M | 94.2M | n/a | n/a | 97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | +19.12% | +197.10% | -68.32% | -11.32% | +2.85% | -10.36% | +9.27% | +5.45% | -1.78% | -5.54% | +11.95% | +1.74% | +4.29% | -7.25% | +16.60% | -3.87% | +7.11% | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |